Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$14.91
-0.24-1.58%
At close: Sep 28, 5:00 PM EST
$14.82
-0.0913-0.61%
After Hours: 4:45 PM EST
Generate Biomedicines Inc (GENB) Stock Price, Quote, News & History
GENBNASDAQ
Generate Biomedicines (GENB) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
FAQ
How do I buy Generate Biomedicines (GENB) stock?
You can purchase shares of Generate Biomedicines (NASDAQ:GENB) through any online brokerage.
Who are Generate Biomedicines (GENB) competitors?
Other companies in Generate Biomedicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
What is the forecast, or price target, for Generate Biomedicines (GENB) stock?
Generate Biomedicines has a consensus price target of $26.40.
What is the current price for Generate Biomedicines (GENB)?
The stock price for Generate Biomedicines (NASDAQ: GENB) is $14.8187 last updated September 28, 2026 at 4:45 PM EDT.
Does Generate Biomedicines (GENB) pay a dividend?
There are no upcoming dividends for Generate Biomedicines.
When is Generate Biomedicines (NASDAQ:GENB) reporting earnings?
Generate Biomedicines does not have any upcoming earnings scheduled.
Is Generate Biomedicines (GENB) going to split?
There is no upcoming split for Generate Biomedicines.
What sector and industry does Generate Biomedicines (GENB) operate in?
Generate Biomedicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
